| Product Code: ETC7358424 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Rotavirus Prophylaxis Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Rotavirus Prophylaxis Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Rotavirus Prophylaxis Market - Industry Life Cycle |
3.4 Greece Rotavirus Prophylaxis Market - Porter's Five Forces |
3.5 Greece Rotavirus Prophylaxis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Greece Rotavirus Prophylaxis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Greece Rotavirus Prophylaxis Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Greece Rotavirus Prophylaxis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of rotavirus prophylaxis in Greece |
4.2.2 Government initiatives promoting vaccination programs |
4.2.3 Growing healthcare infrastructure and access to healthcare services in Greece |
4.3 Market Restraints |
4.3.1 High cost associated with rotavirus prophylaxis vaccines |
4.3.2 Limited reimbursement policies for vaccination in Greece |
4.3.3 Vaccine hesitancy or resistance among certain population groups |
5 Greece Rotavirus Prophylaxis Market Trends |
6 Greece Rotavirus Prophylaxis Market, By Types |
6.1 Greece Rotavirus Prophylaxis Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Greece Rotavirus Prophylaxis Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Greece Rotavirus Prophylaxis Market Revenues & Volume, By Rotarix, 2021- 2031F |
6.1.4 Greece Rotavirus Prophylaxis Market Revenues & Volume, By Rotavac, 2021- 2031F |
6.1.5 Greece Rotavirus Prophylaxis Market Revenues & Volume, By Rotavin-M1, 2021- 2031F |
6.1.6 Greece Rotavirus Prophylaxis Market Revenues & Volume, By Lanzhou Lamb, 2021- 2031F |
6.1.7 Greece Rotavirus Prophylaxis Market Revenues & Volume, By Oral Rehydration Fluid, 2021- 2031F |
6.1.8 Greece Rotavirus Prophylaxis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Greece Rotavirus Prophylaxis Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Greece Rotavirus Prophylaxis Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Greece Rotavirus Prophylaxis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 Greece Rotavirus Prophylaxis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Greece Rotavirus Prophylaxis Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Greece Rotavirus Prophylaxis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Greece Rotavirus Prophylaxis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 Greece Rotavirus Prophylaxis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.5 Greece Rotavirus Prophylaxis Market Revenues & Volume, By Others, 2021- 2031F |
7 Greece Rotavirus Prophylaxis Market Import-Export Trade Statistics |
7.1 Greece Rotavirus Prophylaxis Market Export to Major Countries |
7.2 Greece Rotavirus Prophylaxis Market Imports from Major Countries |
8 Greece Rotavirus Prophylaxis Market Key Performance Indicators |
8.1 Vaccination coverage rate among infants in Greece |
8.2 Number of healthcare facilities offering rotavirus prophylaxis vaccines |
8.3 Rate of adverse events following rotavirus vaccination |
8.4 Percentage of infants receiving the recommended number of doses of rotavirus vaccine |
9 Greece Rotavirus Prophylaxis Market - Opportunity Assessment |
9.1 Greece Rotavirus Prophylaxis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Greece Rotavirus Prophylaxis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Greece Rotavirus Prophylaxis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Greece Rotavirus Prophylaxis Market - Competitive Landscape |
10.1 Greece Rotavirus Prophylaxis Market Revenue Share, By Companies, 2024 |
10.2 Greece Rotavirus Prophylaxis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here